Chimerix Exclusive Worldwide Licensee of Cantex’s Investigational Product DSTAT Has Announced Promising Topline Results from the First Cohort of a Randomized COVID-19 Clinical Trial

WESTON, Fla., Feb. 26, 2021 /PRNewswire/ — Cantex Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing proprietary pharmaceuticals for the treatment of inflammatory lung dise… [read more]

Leave a Comment